Literature DB >> 2001083

NHLBI Workshop summary. Current concepts in idiopathic pulmonary fibrosis: a road map for the future.

R M Cherniack, R G Crystal, A R Kalica.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 2001083     DOI： 10.1164/ajrccm/143.3.680

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  8 in total

1.  Accuracy of mortality data for interstitial lung diseases in New Mexico, USA.

Authors:  D B Coultas; M P Hughes
Journal:  Thorax       Date:  1996-07       Impact factor: 9.139

Review 2.  Oxidants/antioxidants in idiopathic pulmonary fibrosis.

Authors:  W MacNee; I Rahman
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

Review 3.  Idiopathic pneumonia syndrome after bone marrow transplantation: the role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosis.

Authors:  G Shankar; D A Cohen
Journal:  Int J Exp Pathol       Date:  2001-04       Impact factor: 1.925

4.  Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP).

Authors:  J V Barbas-Filho; M A Ferreira; A Sesso; R A Kairalla; C R Carvalho; V L Capelozzi
Journal:  J Clin Pathol       Date:  2001-02       Impact factor: 3.411

5.  The Fibrosis Across Organs Symposium: A Roadmap for Future Research Priorities.

Authors:  Jesse Roman; Teresa R Barnes; Dolly J Kervitsky; Gregory P Cosgrove; Dennis E Doherty; Andrew M Tager; Luca Richeldi; Eric S White; David A Brenner; Lynn M Schnapp; Timothy D Hewitson; Bodh I Jugdutt; Timothy A McKinsey; John D Tosi; Stephen Crane; Kevin K Brown
Journal:  Am J Med Sci       Date:  2019-05       Impact factor: 2.378

6.  Smooth muscle alpha-actin expression and myofibroblast differentiation by TGFbeta are dependent upon MK2.

Authors:  Anne Marie Sousa; Tiegang Liu; Oscar Guevara; Joanne Stevens; Barry L Fanburg; Matthias Gaestel; Deniz Toksoz; Usamah S Kayyali
Journal:  J Cell Biochem       Date:  2007-04-15       Impact factor: 4.429

7.  Aerosolised ribavirin in patients with advanced cryptogenic fibrosing alveolitis: a pilot study.

Authors:  C Agustí; A Xaubet; E Ballester; A Alarcón; C Picado
Journal:  Thorax       Date:  1993-01       Impact factor: 9.139

8.  Lack of MK2 inhibits myofibroblast formation and exacerbates pulmonary fibrosis.

Authors:  Tiegang Liu; Rod R Warburton; Oscar E Guevara; Nicholas S Hill; Barry L Fanburg; Matthias Gaestel; Usamah S Kayyali
Journal:  Am J Respir Cell Mol Biol       Date:  2007-06-28       Impact factor: 6.914
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.